Literature DB >> 34050867

Cancer Biology of the Endoplasmic Reticulum Lectin Chaperones Calreticulin, Calnexin and PDIA3/ERp57.

Shing Tat Theodore Lam1,2, Chinten James Lim3,4.   

Abstract

The lectin chaperones calreticulin (CALR) and calnexin (CANX), together with their co-chaperone PDIA3, are increasingly implicated in studies of human cancers in roles that extend beyond their primary function as quality control facilitators of protein folding within the endoplasmic reticulum (ER). Led by the discovery that cell surface CALR functions as an immunogen that promotes anti-tumour immunity, studies have now expanded to include their potential uses as prognostic markers for cancers, and in regulation of oncogenic signaling that regulate such diverse processes including integrin-dependent cell adhesion and migration, proliferation, cell death and chemotherapeutic resistance. The diversity stems from the increasing recognition that these proteins have an equally diverse spectrum of subcellular and extracellular localization, and which are aberrantly expressed in tumour cells. This review describes key foundational discoveries and highlight recent findings that further our understanding of the plethora of activities mediated by CALR, CANX and PDIA3.

Entities:  

Keywords:  Calnexin; Calreticulin; Drug resistance; Immunogenic cell death; Integrins; Oncogenic signaling; PDIA3

Year:  2021        PMID: 34050867     DOI: 10.1007/978-3-030-67696-4_9

Source DB:  PubMed          Journal:  Prog Mol Subcell Biol        ISSN: 0079-6484


  51 in total

1.  Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.

Authors:  Mark P Chao; Siddhartha Jaiswal; Rachel Weissman-Tsukamoto; Ash A Alizadeh; Andrew J Gentles; Jens Volkmer; Kipp Weiskopf; Stephen B Willingham; Tal Raveh; Christopher Y Park; Ravindra Majeti; Irving L Weissman
Journal:  Sci Transl Med       Date:  2010-12-22       Impact factor: 17.956

2.  Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells.

Authors:  Yichen Chen; Da Ma; Xi Wang; Juan Fang; Xiangqi Liu; Jingjing Song; Xinye Li; Xianyue Ren; Qiusheng Li; Qunxing Li; Shuqiong Wen; Liqun Luo; Juan Xia; Jun Cui; Gucheng Zeng; Lieping Chen; Bin Cheng; Zhi Wang
Journal:  Cancer Immunol Res       Date:  2018-11-06       Impact factor: 11.151

3.  Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line.

Authors:  Silvia Chichiarelli; Elisa Gaucci; Anna Ferraro; Caterina Grillo; Fabio Altieri; Rossana Cocchiola; Valentina Arcangeli; Carlo Turano; Margherita Eufemi
Journal:  Arch Biochem Biophys       Date:  2009-12-06       Impact factor: 4.013

4.  ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum.

Authors:  Helen Coe; Joanna Jung; Jody Groenendyk; Daniel Prins; Marek Michalak
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

5.  Retrotranslocation of the chaperone calreticulin from the endoplasmic reticulum lumen to the cytosol.

Authors:  Nima Afshar; Ben E Black; Bryce M Paschal
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 6.  Protein Quality Control in the Endoplasmic Reticulum.

Authors:  Benjamin M Adams; Michela E Oster; Daniel N Hebert
Journal:  Protein J       Date:  2019-06       Impact factor: 2.371

7.  Suppressive roles of calreticulin in prostate cancer growth and metastasis.

Authors:  Mahesh Alur; Minh M Nguyen; Scott E Eggener; Feng Jiang; Soheil S Dadras; Jeffrey Stern; Simon Kimm; Kim Roehl; James Kozlowski; Michael Pins; Marek Michalak; Rajiv Dhir; Zhou Wang
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

8.  Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.

Authors:  Wei-Fan Chiang; Tzer-Zen Hwang; Tzyh-Chyuan Hour; Lee-Hsin Wang; Chien-Chih Chiu; Hau-Ren Chen; Yu-Jen Wu; Chih-Chun Wang; Ling-Feng Wang; Chen-Yu Chien; Jen-Hao Chen; Chao-Tien Hsu; Jeff Yi-Fu Chen
Journal:  Oral Oncol       Date:  2013-01-31       Impact factor: 5.337

9.  ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer.

Authors:  Min Ho Choe; Joong Won Min; Hong Bae Jeon; Dong-Hyung Cho; Jeong Su Oh; Hyun Gyu Lee; Sang-Gu Hwang; Sungkwan An; Young-Hoon Han; Jae-Sung Kim
Journal:  Oncotarget       Date:  2015-02-20

10.  SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.

Authors:  Aftab Alam; Nandaraj Taye; Sonal Patel; Milind Thube; Jayati Mullick; Vibhuti Kumar Shah; Richa Pant; Tanaya Roychowdhury; Nilanjan Banerjee; Subhrangsu Chatterjee; Rittwika Bhattacharya; Rini Roy; Ashis Mukhopadhyay; Devraj Mogare; Samit Chattopadhyay
Journal:  Neoplasia       Date:  2019-08-15       Impact factor: 5.715

View more
  4 in total

Review 1.  Glycans in autophagy, endocytosis and lysosomal functions.

Authors:  Fulvio Reggiori; Hans-Joachim Gabius; Massimo Aureli; Winfried Römer; Sandro Sonnino; Eeva-Liisa Eskelinen
Journal:  Glycoconj J       Date:  2021-08-14       Impact factor: 2.916

2.  Schweinfurthin induces ICD without ER stress and caspase activation.

Authors:  Ruoheng Zhang; J D Neighbors; T D Schell; R J Hohl
Journal:  Oncoimmunology       Date:  2022-08-03       Impact factor: 7.723

3.  Clinical Significance of Serum Haptoglobin and Protein Disulfide-Isomerase A3 in the Screening, Diagnosis, and Staging of Colorectal Cancer.

Authors:  Yajin Niu; Jun Xue; Xueliang Wu; Ming Qu; Likun Wang; Weizheng Liang; Tian Li
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

Review 4.  ERp57/PDIA3: new insight.

Authors:  Silvia Chichiarelli; Fabio Altieri; Giuliano Paglia; Elisabetta Rubini; Marco Minacori; Margherita Eufemi
Journal:  Cell Mol Biol Lett       Date:  2022-02-02       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.